Medline Inc. (MDLN) SEC Filings & Financial Intelligence
Medline Inc. (MDLN) is a publicly traded company on the Nasdaq, categorized under SIC 3841 (Surgical & Medical Instruments & Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MDLN
CIK: 2046386
Exchange: Nasdaq
SIC 3841: Surgical & Medical Instruments & Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerBlair Komasinski
Audit LocationChicago, Illinois, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-11-06 | — | SCHEDULE 13G/A Filing | 0001193125-26-451977 | View SEC Doc Filr Page |
| 10-Q | 2026-11-04 | 2026-09-26 | 10-Q | 0002046386-26-000063 | View SEC Doc Filr Page |
| 8-K | 2026-11-04 | 2026-11-04 | 8-K | 0002046386-26-000060 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-30 | — | SCHEDULE 13G/A Filing | 0001193125-26-441504 | View SEC Doc Filr Page |
| 8-K | 2026-10-21 | 2026-10-21 | FORM 8-K | 0001104659-26-117844 | View SEC Doc Filr Page |
| 8-K | 2026-10-15 | 2026-10-13 | FORM 8-K | 0001104659-26-116255 | View SEC Doc Filr Page |
| 4 | 2026-10-13 | 2026-10-08 | 4 | 0001193125-26-419824 | View SEC Doc Filr Page |
| 4 | 2026-10-06 | 2026-10-02 | 4 | 0001193125-26-416053 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | 4 | 0001193125-26-361183 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | 4 | 0001193125-26-361185 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 | 0001193125-26-354079 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-11 | — | SCHEDULE 13G/A Filing | 0001193125-26-345223 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-07 | 4 | 0001193125-26-343561 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-06 | OWNERSHIP DOCUMENT | 0001104659-26-092738 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-07 | — | SCHEDULE 13G/A Filing | 0001193125-26-340351 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | 4 | 0001193125-26-340273 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-06 | — | SCHEDULE 13G Filing | 0000315066-26-002081 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-27 | 10-Q | 0002046386-26-000051 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0002046386-26-000049 | View SEC Doc Filr Page |
| 8-K | 2026-07-09 | 2026-07-07 | FORM 8-K | 0001104659-26-082249 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | 4 | 0001193125-26-274355 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | 4 | 0001193125-26-274342 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | 4 | 0001193125-26-274330 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | 4 | 0001193125-26-274323 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | 4 | 0001193125-26-274310 | View SEC Doc Filr Page |